<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2183-8453</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Saúde Ocupacional online]]></journal-title>
<abbrev-journal-title><![CDATA[RPSO]]></abbrev-journal-title>
<issn>2183-8453</issn>
<publisher>
<publisher-name><![CDATA[Ajeogene Serviços Médicos Lda]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2183-84532024000100309</article-id>
<article-id pub-id-type="doi">10.31252/rpso.25.05.2024</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[INTERAÇÃO ENTRE A SÍNDROMA PÓS-COVID (OU COVID LONGO) E A SAÚDE OCUPACIONAL]]></article-title>
<article-title xml:lang="en"><![CDATA[INTERACTION BETWEEN POST-COVID SYNDROME (OR LONG COVID) AND OCCUPATIONAL HEALTH]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chagas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lopes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Ajeogene Serviços Médicos Lda  ]]></institution>
<addr-line><![CDATA[Rio Tinto ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade Católica Portuguesa Instituto de Ciências da Saúde Escola de Enfermagem (Porto)]]></institution>
<addr-line><![CDATA[Gondomar ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,ISEC Lisboa  ]]></institution>
<addr-line><![CDATA[Lisboa ]]></addr-line>
</aff>
<aff id="Af4">
<institution><![CDATA[,departamento de Saúde Ocupacional de uma empresa prestadora de serviços externos durante sete anos  ]]></institution>
<addr-line><![CDATA[Braga ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>06</month>
<year>2024</year>
</pub-date>
<volume>17</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2183-84532024000100309&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2183-84532024000100309&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2183-84532024000100309&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução/enquadramento/objetivos Após alguns anos de exposição às diversas estirpes de COVID-19, existe uma grande percentagem de indivíduos infetados mundialmente, grande parte dos quais em idade ativa. Tendo em conta que numa fração substancial destes existiram sintomas prolongados e com alguma influência para alterar a capacidade de trabalho, iniciou-se uma revisão, no sentido de resumir o que mais pertinente se publicou sobre este assunto.  Metodologia Trata-se de uma Revisão Bibliográfica, iniciada através de uma pesquisa realizada em abril de 2023, nas bases de dados &#8220;CINALH plus with full text, Medline with full text, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Cochrane Methodology Register, Nursing and Allied Health Collection: comprehensive, MedicLatina e RCAAP&#8221;.  Conteúdo Esta síndroma é um conjunto de semiologia multiorgânica que atinge indivíduos previamente infetados, por vezes com duração de vários meses. Trata-se de uma complicação crónica, devido a um estado hiperinflamatório persistente (ainda que a patofisiologia não seja conhecida com clareza) e mesmo após o teste de COVID negativar. Poderá ser justificada através de alterações inflamatórias, hipóxicas, microvasculares e neurodegenerativas; bem como devido aos danos diretos causados pelo vírus em si e/ou pelos efeitos secundários da terapêutica e morbilidades coexistentes. A parte emocional poderá ser associada ao medo de infetar familiares, pelos problemas económicos associados aos custos dos cuidados médicos (em países com sistemas de saúde mais privatizados) e/ou pelo estigma da infeção em si. O diagnóstico é clínico e tanto aparece em indivíduos que foram hospitalizados, como não. Pode implicar morbilidade, sobrecarga do sistema de saúde e de recursos financeiros. Também se designa por Síndroma do COVID longo, termo que, na realidade, surgiu nas redes sociais.  Discussão e Conclusões Dada a temporalidade, os artigos publicados sobre o tema são razoavelmente recentes, não existindo bibliografia anterior sobre este assunto, para discutir os dados obtidos; ainda que alguns sintomas equivalentes também possam ser consequentes a outras infeções, mais prevalentes e/ou antigas, eventualmente por um mecanismo fisiopatológico parecido. Todas as evoluções são possíveis, desde indivíduos assintomáticos durante e após a infeção, como outros com sintomas muito debilitantes e limitadores da sua capacidade laboral. É necessário que a equipa de saúde ocupacional avalie cada caso, usando a classificação de aptidão para ajudar na adequação das tarefas e obtenção de maior desempenho, satisfação laboral e lucro.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction/framework/objectives After a few years of exposure to different strains of COVID-19, there is a large percentage of infected individuals worldwide, most of whom are of working age. Taking into account that in a substantial fraction of these there were prolonged symptoms and with some capacity to alter work capacity, a review was initiated in order to summarize the most pertinent information published on this subject.  Methodology This is a Bibliographic Review, initiated through a search carried out in April 2023, in the databases &#8220;CINALH plus with full text, Medline with full text, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Cochrane Methodology Register, Nursing and Allied Health Collection: comprehensive, MedicLatina and RCAAP&#8221;.  Content This syndrome is a set of multiorgan symptoms/sequelae that affects previously infected individuals, sometimes lasting several months. It is a chronic complication, due to a persistent hyperinflammatory state (although the pathophysiology is not clearly known) and even after the COVID test is negative. It may be justified by inflammatory, hypoxic, microvascular and neurodegenerative changes; by direct damage caused by the virus itself and/or by secondary effects of therapy and co-existing morbidities. The emotional part may be associated with the fear of infecting family members, the economic problems associated with the costs of medical care (in countries with more privatized healthcare systems) and/or the stigma of the infection itself. The diagnosis is clinical and appears both in individuals who have been hospitalized and who have not. It can involve morbidity, overload on the health system and financial resources. It is also called Long COVID Syndrome, a term that actually emerged on social media.  Discussion and Conclusions Given the temporality, the articles published on the topic are reasonably recent, and there is no previous bibliography on this subject to discuss the data obtained; although some symptoms may also be due to other more prevalent and/or old infections, possibly due to a similar pathophysiological mechanism. All evolutions are possible: from asymptomatic individuals during and after the infection to others with very debilitating symptoms that limit their ability to work. It is necessary for the occupational health team to evaluate each case, using the aptitude classification to help adapt tasks and obtain greater performance, job satisfaction and profit.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[síndroma pós-COVID]]></kwd>
<kwd lng="pt"><![CDATA[COVID longa]]></kwd>
<kwd lng="pt"><![CDATA[saúde ocupacional]]></kwd>
<kwd lng="pt"><![CDATA[medicina do trabalho e segurança no trabalho.]]></kwd>
<kwd lng="en"><![CDATA[post-COVID syndrome]]></kwd>
<kwd lng="en"><![CDATA[long COVID]]></kwd>
<kwd lng="en"><![CDATA[occupational health]]></kwd>
<kwd lng="en"><![CDATA[occupational medicine and occupational safety.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Vicente]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Valiente]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Altemir]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Pérez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[López-Pajaro]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic cough in post-COVID syndrome: laryngeal eletromyography findings in vagus nerve neuropathy]]></article-title>
<source><![CDATA[PLOS ONE]]></source>
<year>2023</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e028375</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klocke]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Valentini]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Stolz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gabner]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Joos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Forster]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient´s Experiences with Therapeutic Approches for Post- COVID Syndrome: results of a Crowdsourced research survey]]></article-title>
<source><![CDATA[Annals of Family Medicine]]></source>
<year>2023</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>873-5</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Astill]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sivan]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The relationship between physical activity and long COVID: a cross-sectional study]]></article-title>
<source><![CDATA[International Journal of Environmental Research and Public Health]]></source>
<year>2022</year>
<volume>19</volume>
<page-range>5093</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hallek]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Adorjan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Behrends]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Ertl]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Suttorp]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Lehman]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-Covid Syndrome]]></article-title>
<source><![CDATA[Deutsches Arzteblatt International]]></source>
<year>2023</year>
<volume>120</volume>
<page-range>48-55</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado-Alonso]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cuevas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Oliver-Mas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Díez-Cirarda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado-Alvarez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gil-Moreno]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatigue and Cognitive Dysfunction are associated with Occupational Status in Post-COVID Syndrome]]></article-title>
<source><![CDATA[International Journal of Environmental Research and Public Health]]></source>
<year>2022</year>
<volume>19</volume>
<page-range>13368</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sivan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Parkin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Makover]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[GreenWood]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-Covid Syndrome symptoms, functional disability and clinical severity phenotypes in hospitalized and non-hospitalized individuals: a cross-sectional evaluation from a community COVID rehabilitation service]]></article-title>
<source><![CDATA[Journal of Medical Virology]]></source>
<year>2022</year>
<volume>94</volume>
<page-range>1419-27</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kwong]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Há]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hua]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence patterns and clinical severity of long COVID among chinese medicine telemedicine service users: preliminary results from a cross-sectional study]]></article-title>
<source><![CDATA[International Journal of Environmental Research and Public Health]]></source>
<year>2023</year>
<volume>20</volume>
<page-range>1827</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tempany]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Leonard]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Prior]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Boran]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Reilly]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The potential impact of post-COVID symptoms in the healthcare sector]]></article-title>
<source><![CDATA[Occupational Medicine]]></source>
<year>2021</year>
<volume>71</volume>
<page-range>284-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahmud]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rahman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rassel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Monayem]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Sayeed]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Islam]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh]]></article-title>
<source><![CDATA[PLOS ONE]]></source>
<year>2021</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e0249644</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kayaaslan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Eser]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Kalem]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kaya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kaplan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<collab>Kacard</collab>
<article-title xml:lang=""><![CDATA[Post COVID Syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19]]></article-title>
<source><![CDATA[Journal of Medical Virology]]></source>
<year>2021</year>
<volume>93</volume>
<page-range>6566-74</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stoian]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Procopieusu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Seitan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Scarlet]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-Covid-19 Syndrome: insights into a novel post-infectious systemic disorder]]></article-title>
<source><![CDATA[Journal of Medicine and Life]]></source>
<year>2023</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>195-202</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malik]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jaiswal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Tirupathi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Pillai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-acute COVID-19 Syndrome (PCS) and health-related quality of life (HRQoL)- a systematic review and meta-analyses]]></article-title>
<source><![CDATA[Journal of Medical Urology]]></source>
<year>2022</year>
<volume>94</volume>
<page-range>253-62</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallegos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Martino]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Razumouskiv]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Portillo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Calandra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Caycho-Rodriguez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome post COVID-19 en América Latina y el Caribe: un llamado de atención]]></article-title>
<source><![CDATA[Revista Medica del Rosario]]></source>
<year>2022</year>
<volume>88</volume>
<page-range>114-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shat]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bhattarai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Basnet]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Adhikari]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Adhikari]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatta]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-Covid Syndrome: a prospective study in a tertiary hospital of Nepal]]></article-title>
<source><![CDATA[PLOS ONE]]></source>
<year>2022</year>
<volume>17</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>e272636</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Farahani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ajam]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nacini]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of fluvoxamine on preventing neuropsyquiatric symptoms of post-COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial]]></article-title>
<source><![CDATA[BMC Infectious Diseases]]></source>
<year>2023</year>
<volume>23</volume>
<numero>197</numero>
<issue>197</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bouza]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Botella]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Lledo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez-Pavón]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sindrome Pós-COVID: un documento de reflexión y opinión]]></article-title>
<source><![CDATA[Revista Espanola de Quimioterapia]]></source>
<year>2021</year>
<volume>34</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>269-79</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oronsky]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Larson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hamnond]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Oronsky]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kesari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lybeck]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A review of persistent post-COVID syndrome (PPCS)]]></article-title>
<source><![CDATA[Clinical Reviews in Allergy &amp; Immunology]]></source>
<year>2023</year>
<volume>64</volume>
<page-range>66-74</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Batiha]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Kuraishy]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gareeb]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Welson]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiology in Post-COVID syndromes: a new perspective]]></article-title>
<source><![CDATA[Virology Journal]]></source>
<year>2022</year>
<volume>19</volume>
<page-range>158</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Norrefalk]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Borg]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bileviciute-Ljungar]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Self-scored impairments in functioning and disability in post-COVID syndrome following mild COVID-19 infection]]></article-title>
<source><![CDATA[Journal of Rehabilitation Medicine]]></source>
<year>2021</year>
<volume>53</volume>
<page-range>jrm00239</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naik]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Haldar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Soneja]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mundadan]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Garg]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mittal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post COVID-19 sequelae: a prospective observational study from northeast India]]></article-title>
<source><![CDATA[Drug Discoveries &amp; Therapeutics]]></source>
<year>2021</year>
<volume>15</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>254-60</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munblit]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bobkova]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Spiridonova]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Shikhaleva]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gaminova]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence and Risk Factors for persistent symptoms in adults previous hospitalized for COVID-19]]></article-title>
<source><![CDATA[Clinical and Experimental Allergy]]></source>
<year>2021</year>
<volume>51</volume>
<page-range>1107-20</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moghimi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Napoli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Biller]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Siegler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shekhar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[McCullough]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The neurological manifestations of post-acute sequelae of SARS-COV-2 infection]]></article-title>
<source><![CDATA[Current Neurology and Neuroscience Reports]]></source>
<year>2021</year>
<volume>21</volume>
<page-range>44</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tirelli]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Taibi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chirumbolo]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-COVID Syndrome: a new challenge for medicine]]></article-title>
<source><![CDATA[European Review for Medical and Pharmacological Sciences]]></source>
<year>2021</year>
<volume>25</volume>
<page-range>4420-5</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parums]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Editorial: long COVID or Post-COVID Syndrome and the global impact on Health Care]]></article-title>
<source><![CDATA[Medical Science Monitor]]></source>
<year>2021</year>
<volume>27</volume>
<page-range>e933446</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naureen]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Dautaj]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nodari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fioretti]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dhuli]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Anpilogoc]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Proposal of a food supplement for the management of post-COVID syndrome]]></article-title>
<source><![CDATA[European Review for Medical and Pharmacological Sciences]]></source>
<year>2021</year>
<volume>25</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-73</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kazama]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stabilizing mast cells by commonly used drugs: a novel therapeutic target to relieve post-COVID Syndrome?]]></article-title>
<source><![CDATA[Drug Discoveries &amp; Therapeutics]]></source>
<year>2020</year>
<volume>14</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>259-61</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galván-Tejada]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera-Garcia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Godina-González]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Villagrana-Banuelos]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Amaro]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Herrena-Garcia]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Persistence of COVID-19 symptoms after recovery in Mexican population]]></article-title>
<source><![CDATA[International Journal of Environmental Research and Public Health]]></source>
<year>2020</year>
<volume>17</volume>
<page-range>9367</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scordo]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Richmont]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Munro]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Post-COVID-19 syndrome: theoretical basis, identification and management]]></article-title>
<source><![CDATA[ACN Advanced Critical Care]]></source>
<year>2021</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>188-94</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hatcher]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Werier]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Edgar]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Booth]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cameron]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Corrales-Medina]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enhancing COVID rehabilitation with technology (ECORT): protocol for an open-label, single-site randomized controlled trial evaluating the effectiveness of electronic case management for individuals with persistent COVID-19 symptoms]]></article-title>
<source><![CDATA[Trials]]></source>
<year>2022</year>
<volume>23</volume>
<page-range>728</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prabowo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Rizali]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Habit]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Mulyana]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sulistro]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Albar]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pos Covid-19 Syndrome monitoring in confirmed COVID-19 patients with telemedicine at Cipto Mangumkusumo Hospital]]></article-title>
<source><![CDATA[Acta Medica Indonesiana]]></source>
<year>2022</year>
<volume>54</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>170-5</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Akbarialiabah]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Taghrir]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abdollahi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ghahramani]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Paydar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long COVID, a comprehensive systematic scoping review]]></article-title>
<source><![CDATA[Infection]]></source>
<year>2021</year>
<volume>49</volume>
<page-range>1163-86</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halpin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McIvor]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Whyatt]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Harvey]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[McLean]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Postdischarge symptoms and rehabilitation needs in survivers evaluation]]></article-title>
<source><![CDATA[Journal of Medical Virology]]></source>
<year>2021</year>
<volume>93</volume>
<page-range>1013-22</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tomás]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[O papel do fisioterapeuta na pandemia por SARS-COV-2]]></article-title>
<source><![CDATA[Saúde &amp; Tecnologia]]></source>
<year>2020</year>
<page-range>e29-33</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
